|
Market Closed -
Euronext Paris
11:55:00 2026-11-06 EST
|
5-day change | 1st Jan Change | ||
| 1.975 EUR | -1.00% |
|
-4.59% | -27.12% |
| 10-01 | Taconic Biosciences, Inc. And genOway Partner To Expand U.S. Access To Advanced Humanized Mouse Models | CI |
| 09-23 | GenOway teams up with Taconic Biosciences to accelerate in the United States |  |
| Market Cap | 18.21M 20.3M 16.64M 15.19M 28.62M 1.91B 29.52M 201M 79.99M 1.02B 76.21M 74.57M 3.21B | P/E 2024 * |
-
| P/E 2025 | - |
|---|---|---|---|---|---|
| Enterprise Value | 24.93M 27.79M 22.78M 20.8M 39.18M 2.61B 40.42M 275M 109M 1.39B 104M 102M 4.4B | EV / Sales 2024 |
1.36x | EV / Sales 2025 | 1.22x |
| Free-Float |
59.02% | Yield 2024 * |
-
| Yield 2025 | - |
Euronext ParisEUR
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| ALGEN | Real-time | |
Deutsche Boerse AG
| JEH | Delayed | |
|
Boerse Muenchen
| JEH | Real-time | |
|
Börse Stuttgart
| JEH | Delayed |
| 1 day | -1.00% | ||
| 1 week | -4.59% | ||
| Current month | -4.59% | ||
| 1 month | -17.71% | ||
| 3 months | -21.31% | ||
| 6 months | -18.72% | ||
| Current year | -27.12% |
| 1 week | 1.91 |  | 2.19 |
| 1 month | 1.91 | | 2.31 |
| Current year | 1.91 | | 2.79 |
| 1 year | 1.91 | | 2.88 |
| 3 years | 1.91 | | 4.91 |
| 5 years | 1.91 | | 4.91 |
| 10 years | 1 | | 7.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Chief Operating Officer | - | 1999-02-28 | |
Benjamin Bruneau
DFI | Director of Finance/CFO | - | 2015-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 1999-02-28 | |
| Chairman | - | - | |
Laurent Fraisse
BRD | Director/Board Member | - | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/20/22 | Buy | Chief Executive Officer | 12,500 | 0.1376% | ||
| 11/17/21 | Sell | Chief Executive Officer | 5,000 | 0.0553% | ||
| 11/13/21 | Sell | Founder | 1,147 | 0.0127% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.00% | -4.59% | -20.36% | -51.83% | 20.3M | |
| -4.83% | +3.51% | +55.00% | +63.79% | 66.7B | |
| +0.02% | +1.07% | +11.72% | +75.63% | 56.88B | |
| -1.34% | +2.98% | +25.08% | +100.18% | 56.53B | |
| +5.09% | +9.89% | +27.19% | +105.85% | 46.49B | |
| +2.62% | +1.68% | +29.16% | +35.86% | 44.8B | |
| +8.24% | +0.51% | +215.16% | +794.74% | 41.59B | |
| -1.86% | +10.13% | +28.14% | +55.48% | 35.35B | |
| -2.97% | -9.84% | +90.91% | +73.49% | 33.29B | |
| +5.19% | +1.62% | -39.69% | +368.87% | 25.1B | |
| Average | +0.92% | +1.92% | +42.23% | +162.21% | 40.67B | |
| Weighted average by Cap. | +0.65% | +3.07% | +49.90% | +165.86% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 25.84M 28.81M 23.62M 21.56M 40.62M 2.71B 41.9M 285M 114M 1.45B 108M 106M 4.56B | 26.03M 29.02M 23.79M 21.72M 40.91M 2.73B 42.2M 287M 114M 1.46B 109M 107M 4.6B |
| Net income | 1.83M 2.04M 1.67M 1.53M 2.88M 192M 2.97M 20.17M 8.04M 102M 7.66M 7.5M 323M | 928K 1.03M 848K 774K 1.46M 97.24M 1.5M 10.22M 4.08M 51.88M 3.88M 3.8M 164M |
| Net Debt | 623K 695K 569K 520K 979K 65.29M 1.01M 6.86M 2.74M 34.84M 2.61M 2.55M 110M | 6.72M 7.49M 6.14M 5.6M 10.56M 704M 10.89M 74.01M 29.51M 376M 28.12M 27.51M 1.19B |
Employees
163
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-06 | €1.975 | -1.00% | 3,699 |
| 26-11-05 | €1.995 | +4.18% | 8,820 |
| 26-11-04 | €1.915 | -7.93% | 93,187 |
| 26-11-03 | €2.080 | +2.46% | 1,762 |
| 26-11-02 | €2.030 | -1.93% | 7,936 |
- Stock Market
- Stocks
- ALGEN Stock
Select your edition
All financial news and data tailored to specific country editions
